Growth, Pathogenesis, and Serological Characteristics of the Japanese Encephalitis Virus Genotype IV Recent Strain 19CxBa-83-Cv

• Published in: Viruses Vol. 15; no. 1; p. 239
• Main Authors: Tajima, Shigeru, Maeki, Takahiro, Nakayama, Eri, Faizah, Astri Nur, Kobayashi, Daisuke, Isawa, Haruhiko, Maekawa, Yoshihide, Bendryman, Sri Subekti, Mulyatno, Kris Cahyo, Rohmah, Etik Ainun, Mori, Yasuko, Sawabe, Kyoko, Ebihara, Hideki, Lim, Chang-Kweng
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 14.01.2023; MDPI
• Subjects: Animals; Antibodies, Neutralizing; Antibodies, Viral; Antigenic characteristics; Chlorocebus aethiops; Encephalitis; Encephalitis Virus, Japanese; Encephalitis Viruses, Japanese; Encephalitis, Japanese; Genomes; Genotype; Genotype & phenotype; genotype IV; Genotypes; Hogs; Immunization; Invasiveness; Japanese encephalitis virus; Maximum likelihood method; Mice; Mosquitoes; Neuroblastoma; Neuroblastoma cells; Neurovirulence; pathogenicity; Patients; Phylogenetics; Serology; Vaccines; Vero Cells; Viruses; Torres Strait Islands; Malaysia; Australia; United States > US; Japan; Indonesia; Japanese encephalitis virus; pathogenicity; genotype IV; serology
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v15010239

Genotype IV Japanese encephalitis (JE) virus (GIV JEV) is the least common and most neglected genotype in JEV. We evaluated the growth and pathogenic potential of the GIV strain 19CxBa-83-Cv, which was isolated from a mosquito pool in Bali, Indonesia, in 2019, and serological analyses were also conducted. The growth ability of 19CxBa-83-Cv in Vero cells was intermediate between that of the genotype I (GI) strain Mie/41/2002 and the genotype V (GV) strain Muar, whereas 19CxBa-83-Cv and Mie/41/2002 grew faster than Muar in mouse neuroblastoma cells. The neuroinvasiveness of 19CxBa-83-Cv in mice was higher than that of Mie/41/2002 but lower than that of Muar; however, there were no significant differences in neurovirulence in mice among the three strains. The neutralizing titers of sera from 19CxBa-83-Cv- and Mie/41/2002-inoculated mice against 19CxBa-83-Cv and Mie/41/2002 were similar, whereas the titers against Muar were lower than those of the other two viruses. The neutralizing titers of JE vaccine-inoculated mouse pool serum against 19CxBa-83-Cv and Muar were significantly lower than those against Mie/41/2002. The neutralizing titers against the three viruses were similar in three out of the five serum samples from GI-infected JE patients, although the titers against Mie/41/2002 were higher than those against 19CxBa-83-Cv and Muar in the remaining two sera samples. In summary, we identified the basic characteristics of 19CxBa-83-Cv, but further studies are needed to better understand GIV JEV.